Does detection of circulating ONYX-015 genome by polymerase chain reaction indicate vector replication?

被引:5
作者
Yver, A [1 ]
机构
[1] Aventis Pharmaceut Inc, Bridgewater, NJ 08807 USA
关键词
D O I
10.1200/JCO.2001.19.12.3155
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:3155 / 3156
页数:2
相关论文
共 4 条
[1]   Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma [J].
Clayman, GL ;
El-Naggar, AK ;
Lippman, SM ;
Henderson, YC ;
Frederick, M ;
Merritt, JA ;
Zumstein, LA ;
Timmons, TM ;
Liu, TJ ;
Ginsberg, L ;
Roth, JA ;
Hong, WK ;
Bruso, P ;
Goepfert, H .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (06) :2221-2232
[2]  
Constenia-Figueiras M., 1999, Proceedings of the American Association for Cancer Research Annual Meeting, V40, P189
[3]  
CONSTENLAFIGUEI.M, 1999, P AM SOC CLIN ONCOL, V18, pA444
[4]   Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer [J].
Nemunaitis, J ;
Khuri, F ;
Ganly, I ;
Arseneau, J ;
Posner, M ;
Vokes, E ;
Kuhn, J ;
McCarty, T ;
Landers, S ;
Blackburn, A ;
Romel, L ;
Randlev, B ;
Kaye, S ;
Kirn, D .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (02) :289-298